Does Routine Triple-Time-Point FDG PET/CT Imaging Improve the Detection of Liver Metastases?

• Main Authors: Yu-An Yen, Wen-Sheng Huang, Chuang-Hsin Chiu, Yu-Chang Tyan, Jhi-Joung Wang, Li-Chun Wu, I Jung Feng, Chiang Hsuan Lee
• Format: Article
• Language: English
• Published: MDPI AG 2020-08-01
• Series: Diagnostics
• Subjects: dual-time-point; fluorodeoxyglucose; liver metastases; positron emission tomography/computed tomography; triple-time-point
• Online Access: https://www.mdpi.com/2075-4418/10/9/609

Prior reports have demonstrated the improved ability of delayed fluorine-18 (¹⁸F) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging (dual-time-point imaging) in detecting more patients with liver metastases. To evaluate whether routine triple-time-point FDG PET/CT imaging improves the detection of liver metastasis not visualized on initial imaging. To our knowledge, no triple-time-point imaging has been reported. This retrospective study included total 310 patients with various malignancies who underwent PET/CT scans. Triple-time-point imaging including the liver was obtained. The comparison between negative and positive liver lesions on delayed imaging for patients with initial negative imaging were analyzed. Of the 310 patients, 286 did not exhibit liver lesions on initial imaging, but six of the 286 patients exhibited lesions on delayed imaging. No additional liver lesions were detected on further delayed imaging in the 286 patients. The other 24 patients with liver lesions identified on initial imaging still showed lesions on delayed and further delayed imaging. The analysis showed a significant difference in the percentage of colorectal cancer (66.7%) and liver lesions before the PET scan (50.0%) compared with unchanged results (22.1% and 3.9%, respectively). Routine triple-time-point imaging did not improve the detection of liver metastases; however, it may be recommended in patients with colorectal cancer and liver lesions before the PET scan.